MAPT and epilepsy: The relatively higher risk of epilepsy for AD- and VD-NCD subtypes may be due to the potential epileptogenic effect of amyloid β and tau pathology, a shared genotype such as APOE4, and increased markers of cerebrovascular disease on brain imaging in people with epilepsy (Sen et al., 2018).